Australia's most trusted
source of pharma news
Wednesday, 15 January 2025
Posted 1 March 2024 AM
AstraZeneca stood its ground on the use of genetic testing results in life insurance underwriting this week, joining supporters of a total ban.
The government is currently considering the results of a consultation on the topic following a Monash report called A-GLIMMER which found ongoing discrimination is taking place, deterring Aussies from undergoing testing.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.